Analyst
Barenberg
Equibles does not estimate personal net worth.
Louisa Hector is recorded as Analyst at Barenberg. Louisa Hector has spoken on 3 earnings calls across 3 companies, most recently for Merck & Co., Inc. on August 4, 2026. Those appearances were for Merck & Co., Inc. (MRK), AbbVie Inc. (ABBV) and Bristol Myers Squibb Co (BMY). The companies whose calls Louisa Hector spoke on are classified in the Healthcare sector.
“Just the specific wording on the label, which talks about LDL abduction, But then that cardiovascular outcomes trials have shown to be, have shown that you get a reduction in LDL also leads to the reduction in events specifically for monoclonal antibody PCSK9 inhibitors.”
“I wonder if you can give us any kind of early indication from formulary season. I'm hearing levels of confidence, as usual, on SkyRizzy and RimVox. They're just sort of checking around pricing environments and impacts of some of their head-to-head studies from competitors.”
“I wanted to just check on Milvexian a little bit around how nimble you can be around launch costs. Do you need to pull back on any investment due to this delay, or is it just, you know, a matter of a quarter?”
Barenberg
Analyst
Transcript header (unverified)
Drug Manufacturers - General · Healthcare
ABBV
Drug Manufacturers - General · Healthcare
Drug Manufacturers - General · Healthcare
